story of the week
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
JAMA Intern Med 2024 Sep 16;[EPub Ahead of Print], F Kanwal, JR Kramer, L Li, YX Yang, Y Cao, X Yu, R Samuel, B Ali, R Desiderio, G Cholankeril, M Bajaj, HB El-Serag, SM AschFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.